Saline versus 5% dextrose in water as a drug diluent for critically ill patients: a retrospective cohort study.

Critical care Dextrose in water Diluent Hyperglycemia Hypernatremia Saline

Journal

Journal of intensive care
ISSN: 2052-0492
Titre abrégé: J Intensive Care
Pays: England
ID NLM: 101627304

Informations de publication

Date de publication:
2020
Historique:
received: 09 07 2020
accepted: 03 09 2020
entrez: 18 9 2020
pubmed: 19 9 2020
medline: 19 9 2020
Statut: epublish

Résumé

The choice of intravenous infusion products for critically ill patients has been studied extensively because it can affect prognosis. However, there has been little research on drug diluents in this context. The purpose of this study is to evaluate the impact of diluent choice (saline or 5% dextrose in water [D5W]) on electrolyte abnormalities, blood glucose control, incidence of acute kidney injury (AKI), and mortality. This before-after, two-group comparative, retrospective study enrolled adult patients who stayed for more than 48 h in a general intensive care unit from July 2015 to December 2018. We changed the default diluent for intermittent drug sets in our electronic ordering system from D5W to saline at the end of 2016. We included 844 patients: 365 in the D5W period and 479 in the saline period. Drug diluents accounted for 21.4% of the total infusion volume. The incidences of hypernatremia and hyperchloremia were significantly greater in the saline group compared to the D5W group (hypernatremia 27.3% vs. 14.6%, Changing the diluent default from D5W to saline had no effect on blood glucose control and increased the incidences of hypernatremia and hyperchloremia.

Sections du résumé

BACKGROUND BACKGROUND
The choice of intravenous infusion products for critically ill patients has been studied extensively because it can affect prognosis. However, there has been little research on drug diluents in this context. The purpose of this study is to evaluate the impact of diluent choice (saline or 5% dextrose in water [D5W]) on electrolyte abnormalities, blood glucose control, incidence of acute kidney injury (AKI), and mortality.
METHODS METHODS
This before-after, two-group comparative, retrospective study enrolled adult patients who stayed for more than 48 h in a general intensive care unit from July 2015 to December 2018. We changed the default diluent for intermittent drug sets in our electronic ordering system from D5W to saline at the end of 2016.
RESULTS RESULTS
We included 844 patients: 365 in the D5W period and 479 in the saline period. Drug diluents accounted for 21.4% of the total infusion volume. The incidences of hypernatremia and hyperchloremia were significantly greater in the saline group compared to the D5W group (hypernatremia 27.3% vs. 14.6%,
CONCLUSIONS CONCLUSIONS
Changing the diluent default from D5W to saline had no effect on blood glucose control and increased the incidences of hypernatremia and hyperchloremia.

Identifiants

pubmed: 32944250
doi: 10.1186/s40560-020-00489-6
pii: 489
pmc: PMC7488509
doi:

Types de publication

Journal Article

Langues

eng

Pagination

69

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare that they have no competing interests.

Références

J Crit Care. 2013 Aug;28(4):405-12
pubmed: 23369520
Br J Surg. 2015 Jan;102(1):24-36
pubmed: 25357011
Clin J Am Soc Nephrol. 2012 May;7(5):712-9
pubmed: 22422536
Intensive Care Med. 2007 Dec;33(12):2093-100
pubmed: 17928994
Chest. 1991 Dec;100(6):1619-36
pubmed: 1959406
JAMA. 2012 Oct 17;308(15):1566-72
pubmed: 23073953
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
N Engl J Med. 2012 Sep 20;367(12):1108-18
pubmed: 22992074
Clin Diabetes. 2019 Jan;37(1):11-34
pubmed: 30705493
Crit Care Med. 2015 Sep;43(9):1938-44
pubmed: 26154934
N Engl J Med. 2018 Mar 1;378(9):829-839
pubmed: 29485925
Anesthesiology. 2006 Aug;105(2):244-52
pubmed: 16871057
J Crit Care. 2011 Apr;26(2):175-9
pubmed: 20619601
Crit Care Med. 2018 Aug;46(8):1217-1223
pubmed: 29727367
Am J Med Sci. 2016 Jun;351(6):601-5
pubmed: 27238923
Anesth Analg. 2013 Aug;117(2):412-21
pubmed: 23757473
Br J Anaesth. 2016 Jan;116(1):63-9
pubmed: 26675950
J Crit Care. 2014 Jun;29(3):390-4
pubmed: 24603000
Crit Care Med. 2012 Dec;40(12):3251-76
pubmed: 23164767
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088

Auteurs

Yukari Aoyagi (Y)

Intensive Care Unit, Department of Anesthesiology, The Jikei University Hospital, 3-19-18, Nishi-Shinbashi Minato-ku, Tokyo, 105-8471 Japan.

Takuo Yoshida (T)

Intensive Care Unit, Department of Anesthesiology, The Jikei University Hospital, 3-19-18, Nishi-Shinbashi Minato-ku, Tokyo, 105-8471 Japan.

Shigehiko Uchino (S)

Intensive Care Unit, Department of Anesthesiology, The Jikei University Hospital, 3-19-18, Nishi-Shinbashi Minato-ku, Tokyo, 105-8471 Japan.

Masanori Takinami (M)

Intensive Care Unit, Department of Anesthesiology, The Jikei University Hospital, 3-19-18, Nishi-Shinbashi Minato-ku, Tokyo, 105-8471 Japan.

Shoichi Uezono (S)

Intensive Care Unit, Department of Anesthesiology, The Jikei University Hospital, 3-19-18, Nishi-Shinbashi Minato-ku, Tokyo, 105-8471 Japan.

Classifications MeSH